Léane Heliez, Charles Ricordel, Philippe Becuwe, Rémy Pedeux
Current opinion in pharmacology 2023 FebThe INhibitor of Growth (ING) proteins (ING1, ING2, ING3, ING4 and ING5) are a family of epigenetic regulators. Their decreased expression in numerous cancers led to identifying the ING proteins as gatekeeper tumor suppressors as they regulate cell cycle progression, apoptosis and senescence. Subsequently, they were also described as caretaker tumor suppressors through their involvement in DNA replication and the DNA damage response (DDR). Recent studies have identified new interactions of the ING proteins with proteins or pathways implicated in cell proliferation, the maintenance of stem cells pluripotency or the DDR. Furthermore, the ING proteins have been identified as regulators of ribosomal RNA synthesis and of mRNA stability and as regulators of mitochondrial DNA transcription resulting in the regulation of metabolism. These new findings highlight new antitumorigenic activities of the ING proteins that are potential targets for cancer treatment. Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.
Léane Heliez, Charles Ricordel, Philippe Becuwe, Rémy Pedeux. Newly identified tumor suppressor functions of ING proteins. Current opinion in pharmacology. 2023 Feb;68:102324
PMID: 36521226
View Full Text